Medicines for four rare diseases become cheaper due to domestic production
Drugs for four of these diseases -Tyrosinemia Type 1, Gaucher's Disease, Wilson's Disease and Dravet-Lennox Gastaut Syndrome - along with sickle cell Anemia have been approved and are being manufactured indigenously. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - November 25, 2023 Category: Pharmaceuticals Source Type: news
EXCLUSIVE: Woman, 21, needs a life-saving blood transfusion after vaping ONCE caused 'acute chest syndrome'
The woman, who was from India, started to suffer pain in her back and ribs shortly after using the vape. She suffered from sickle cell anemia, which raises the risk of complications with vapes. (Source: the Mail online | Health)
Source: the Mail online | Health - November 23, 2023 Category: Consumer Health News Source Type: news
Your tiredness may be a sign of anemia. These iron-rich foods can help.
If you suspect that you’re low in iron, such as fatigue, shortness of breath, and cold hands or feet, see your health-care provider before taking action. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - November 20, 2023 Category: Consumer Health News Authors: Sharon Liao Source Type: news
Crispr Therapeutics (NASDAQ:CRSP) Notches Up on World-First Therapy - TipRanks.com
Great news emerged out of biotech stock Crispr Therapeutics (NASDAQ:CRSP), particularly for those who suffer from sickle-cell anemia. A new treatment for the disease was created using the genetic modification tool, and it’s given Crispr stock a boost, up nearly 5% in Tuesday morning’s trading…#crisprtherapeutics #unitedkingdom #exacel #samarthkulkarni #moderatebuy #crsp #holds (Source: Reuters: Health)
Source: Reuters: Health - November 17, 2023 Category: Consumer Health News Source Type: news
Sickle-Cell Treatment Created With Gene Editing Wins U.K. Approval
The first treatment that relies on CRISPR is expected to receive U.S. approval next month. But it may cost millions of dollars per patient. (Source: NYT Health)
Source: NYT Health - November 17, 2023 Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Genetics and Heredity Genetic Engineering Blood Bone Marrow Hemoglobin Crispr (DNA) Drugs (Pharmaceuticals) CRISPR Therapeutics Vertex Pharmaceuticals Inc Source Type: news
CRISPR Therapy Gets U.K. Approval, the First in the World
Britain’s medicines regulator has authorized the world’s first gene therapy treatment for sickle cell disease, in a move that could offer relief to thousands of people with the crippling disease in the U.K.
[time-brightcove not-tgx=”true”]
In a statement on Thursday, the Medicines and Healthcare Regulatory Agency said it approved Casgevy, the first medicine licensed using the gene editing tool CRISPR, which won its makers a Nobel prize in 2020.
The agency approved the treatment for patients with sickle cell disease and thalassemia who are 12 years old and over. Casgevy is made by Vertex ...
Source: TIME: Health - November 16, 2023 Category: Consumer Health News Authors: MARIA CHENG / AP Tags: Uncategorized Drugs wire Source Type: news
Why Am I Always So Tired?
WebMD explains conditions that might cause you to feel sluggish during the day, such as anemia, thyroid trouble, sleep apnea, diabetes, heart disease, depression, and menopause. (Source: WebMD Health)
Source: WebMD Health - November 15, 2023 Category: Consumer Health News Source Type: news
AHA: No Real Benefit Seen for Liberal Transfusion Strategy in AMI, Anemia
TUESDAY, Nov. 14, 2023 -- For patients with acute myocardial infarction and anemia, a liberal transfusion strategy does not significantly reduce the risk for recurrent myocardial infarction or death compared with a restrictive strategy, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 14, 2023 Category: Pharmaceuticals Source Type: news
In MI With Anemia, Results May Favor Liberal Transfusion In MI With Anemia, Results May Favor Liberal Transfusion
Although the primary outcome was not statistically different between a liberal and more restrictive transfusion strategy, secondary results suggest some advantages for the liberal approach.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - November 11, 2023 Category: Internal Medicine Tags: Cardiology News Source Type: news
‘The Marvels’ Sinks to MCU-Low $48 Million Box Office Opening
“The Marvels” will set a new record for the worst opening weekend in the history of the Marvel Cinematic Universe, as the sequel to 2019’s “Captain Marvel” posted an anemic $21.3 million Friday total and is heading towards a $48 million domestic launch from 4,030 theaters, according to industry…#marvels #captainmarvel #marvelstudios #incrediblehulk #flash #cinemascore #mcu #secretinvasion #thewrap (Source: Reuters: Health)
Source: Reuters: Health - November 11, 2023 Category: Consumer Health News Source Type: news
Different transfusion approaches for helping heart attack patients who develop anemia recover led to similar 30-day outcomes
NIH-funded findings suggest potential benefit of giving more blood to patients. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - November 11, 2023 Category: American Health Source Type: news
Transfusion Thresholds Square Off in Acute Myocardial Infarction
(MedPage Today) -- PHILADELPHIA -- For acute myocardial infarction (MI) patients with anemia, being more liberal with blood transfusion thresholds didn't significantly impact risk of recurrent heart attack or death in the MINT trial, although... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - November 11, 2023 Category: Cardiology Source Type: news
FDA considers first CRISPR gene editing treatment that may cure sickle cell
At age 45, Dr. Lakiea Bailey said, for the longest time, that she was the oldest person with sickle cell anemia that she knew. The executive director of the nonprofit patient advocacy group the Sickle Cell Consortium was diagnosed with sickle cell disease at age three. Because of it, she’s had…#lakieabailey #sicklecellconsortium #bailey #fda #boston #crispr #africanamericans #stephaniekrogmeier #fyodorurnov #independentcommittee (Source: Reuters: Health)
Source: Reuters: Health - November 1, 2023 Category: Consumer Health News Source Type: news
Panel Tells F.D.A. That CRISPR Sickle Cell Cure Is Safe Enough for Patients
The decision by an advisory committee may lead to Food and Drug Administration approval of the first treatment for humans that uses the CRISPR gene-editing system. (Source: NYT Health)
Source: NYT Health - October 31, 2023 Category: Consumer Health News Authors: Gina Kolata Tags: Sickle Cell Anemia Crispr (DNA) Food and Drug Administration Vertex Pharmaceuticals Inc CRISPR Therapeutics Clinical Trials Genetic Engineering Drugs (Pharmaceuticals) Source Type: news
New Gene Therapies for Sickle Cell Anemia to be Considered by FDA
MONDAY, Oct. 30, 2023 -- Patients with sickle cell disease may soon have two new treatments to try. On Tuesday, a U.S. Food and Drug Administration advisory committee will weigh the merits of a new gene therapy for the painful, inherited condition.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 30, 2023 Category: Pharmaceuticals Source Type: news
